ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care.

Prof Ayelazuno said militarised operations such as Operation Vanguard and Operation Halt had not addressed the root causes of galamsey and only reinforced the shadow state. He urged President John ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, ...